OncoMatch

OncoMatch/Clinical Trials/NCT07285044

The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas

Is NCT07285044 recruiting? Yes, currently enrolling (May 2026). This Phase 2 trial studies multiple treatments including Cancer Therapeutic Procedure and Cancer Therapeutic Procedure for amyloidosis.

Phase 2RecruitingMayo ClinicNCT07285044Data as of May 2026

Treatment: Cancer Therapeutic Procedure · Cancer Therapeutic ProcedureThis phase II trial studies whether providing cancer treatment in the home is preferred over the traditional clinic setting and if it improves treatment satisfaction in cancer patients living in the Florida Panhandle and surrounding areas. Typically, drug-related cancer care is provided at a medical center which causes patients to have to spend considerable time away from their family, friends, and familiar surroundings. This may add to the physical, emotional, social, and financial burden for patients and their families during this difficult time in their lives. The Cancer Connected Access and Remote Expertise (CARE) Beyond Walls (CCBW) program uses a specialized care team trained to provide cancer treatment in the patient's home setting. It is designed to support remote connection between the home health team and providers and Mayo clinic. This may be preferred over the traditional clinic setting which may improve treatment satisfaction in cancer patients living in the Florida Panhandle and surrounding areas.

Check if I qualify

Extracted eligibility criteria

Cancer type

Tumor Agnostic

Urothelial Carcinoma

Breast Carcinoma

Cervical Cancer

Colorectal Cancer

Endometrial Cancer

Ovarian Cancer

Gastric Cancer

Esophageal Carcinoma

Glioblastoma

Hepatocellular Carcinoma

Hodgkin Lymphoma

Non-Small Cell Lung Carcinoma

Non-Hodgkin Lymphoma

Melanoma

Multiple Myeloma

Myelodysplastic Syndrome

Pancreatic Cancer

Prostate Cancer

Renal Cell Carcinoma

Performance status

ECOG 0–3(Limited self-care)

Prior therapy

Cannot have received: investigational agent

Receiving any investigational agent which would be considered as a treatment for the primary neoplasm.

Structured fields extracted by AI. May contain errors — verify against the official protocol.

US trial sites

  • Mayo Clinic in Florida · Jacksonville, Florida

Showing up to 5 US sites. See all sites on ClinicalTrials.gov →

Could you qualify for this trial?

Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.

Check if I qualify